In a recent press release, Tris Pharma in Monmouth Junction, New Jersey, announced the launch of two phase 3 trials — ...
Group Purchasing Organizations of 'Big 3' PBMs Cloud Transparency, Says Critic | PBMI 2024 Greg Baker, CEO of AffirmedRx, did ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
Digital technology, AI and other tools will allow for many specialty infusion therapies to be administered in ambulatory ...
Telehealth has become a permanent part of U.S. healthcare delivery, and states are taking steps to regulate it ...
The Type 1 Diabetes Grand Challenge has provided awards to six universities —including three in the United States — to fund ...
The IQVIA vice president and frequent speaker at pharmacy and managed care meetings said he will retire in May 2025.
Complexity surrounding HIV treatments leads to an overall decline in adherence, according to the results of a study published ...
Changes to the methodology for how the Health Equity Index is assessed could see Medicare Advantage Star ratings — and ...
Technology is advancing to allow the prior authorization process to operate behind the scenes through electronic systems that ...
Cell and gene therapies are becoming almost an everyday clinical reality. But the price tags? They still have shock value.
Will Congress Pass PBM Legislation This Year? It Is 'Highly Likely,' Says Patrick Cooney | PBMI 2024
Patrick Cooney, president of The Federal Group, a Washington, D.C., lobbying firm says prospects for legislation passing this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results